Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis
- PMID: 27152765
- DOI: 10.1080/21678421.2016.1177088
Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis
Abstract
Executive dysfunction is a core feature of amyotrophic lateral sclerosis (ALS) and is associated with brain atrophy in cortical and subcortical regions. Social cognitive deficits may also be a prominent feature of ALS. This study investigated executive, and social cognitive performance, in a population based cohort of patients with ALS, stratified by disease onset. Participants were recruited as part of a population based study investigating cognitive decline in ALS. Patients carrying pathogenic C9orf72 hexanucleotide repeat were excluded. Participants were stratified based on bulbar (n = 20) or spinal (n = 39) disease onset (n = 59). Matched healthy controls were used to generate culturally specific comparative data for within-patient analyses (n = 59). Results showed that ALS patients performed significantly worse than controls on a number of measures of executive function. When sub-stratified by disease onset, there was a significant difference between bulbar- and spinal-onset patients with respect to the 'Reading the Mind in the Eyes' Test scores (p < 0.001). Conversely, standardized scores of executive function did not differ between the patient groups. In conclusion, patients performed significantly worse than matched controls on measures of executive function. Bulbar-onset ALS patients evidenced more social-affective deficits compared to spinal-onset patients, with matched performance on measures of executive function.
Keywords: ALS; executive function; neuropsychology; social cognition.
Similar articles
-
Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study.PLoS One. 2016 Aug 24;11(8):e0160850. doi: 10.1371/journal.pone.0160850. eCollection 2016. PLoS One. 2016. PMID: 27556398 Free PMC article.
-
Can executive cognitive measures differentiate between patients with spinal- and bulbar-onset amyotrophic lateral sclerosis?Arch Clin Neuropsychol. 2012 May;27(3):348-54. doi: 10.1093/arclin/acs031. Epub 2012 Mar 8. Arch Clin Neuropsychol. 2012. PMID: 22403771
-
Neural substrate of cognitive theory of mind impairment in amyotrophic lateral sclerosis.Cortex. 2015 Apr;65:19-30. doi: 10.1016/j.cortex.2014.12.010. Epub 2014 Dec 29. Cortex. 2015. PMID: 25618325
-
The cognitive profile of ALS: a systematic review and meta-analysis update.J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):611-9. doi: 10.1136/jnnp-2015-310734. Epub 2015 Aug 17. J Neurol Neurosurg Psychiatry. 2016. PMID: 26283685 Review.
-
Cognitive impairment in amyotrophic lateral sclerosis.Lancet Neurol. 2007 Nov;6(11):994-1003. doi: 10.1016/S1474-4422(07)70265-X. Lancet Neurol. 2007. PMID: 17945153 Review.
Cited by
-
A 20-Year Systematic Review of the 'Reading the Mind in the Eyes' Test across Neurodegenerative Conditions.Brain Sci. 2023 Aug 31;13(9):1268. doi: 10.3390/brainsci13091268. Brain Sci. 2023. PMID: 37759869 Free PMC article. Review.
-
The involvement of language-associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations.Brain Behav. 2023 Nov;13(11):e3250. doi: 10.1002/brb3.3250. Epub 2023 Sep 11. Brain Behav. 2023. PMID: 37694825 Free PMC article.
-
Bulbar involvement and cognitive features in amyotrophic lateral sclerosis: a retrospective study on 347 patients.Front Aging Neurosci. 2023 Jul 20;15:1217080. doi: 10.3389/fnagi.2023.1217080. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37547740 Free PMC article.
-
Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers.J Neurol. 2023 Sep;270(9):4235-4247. doi: 10.1007/s00415-023-11764-5. Epub 2023 May 13. J Neurol. 2023. PMID: 37178170 Free PMC article.
-
Brainstem-cortex disconnection in amyotrophic lateral sclerosis: bulbar impairment, genotype associations, asymptomatic changes and biomarker opportunities.J Neurol. 2023 Jul;270(7):3511-3526. doi: 10.1007/s00415-023-11682-6. Epub 2023 Apr 6. J Neurol. 2023. PMID: 37022479 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
